Mr Glenn Mitchell Cratty, LICSW | |
341 Vt Rt 315, Rupert, VT 05768-0029 | |
(802) 287-1515 | |
Not Available |
Full Name | Mr Glenn Mitchell Cratty |
---|---|
Gender | Male |
Speciality | Clinical Social Worker |
Experience | 47 Years |
Location | 341 Vt Rt 315, Rupert, Vermont |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073677142 | NPI | - | NPPES |
00059411 | Other | VT | BCBS |
1006793 | Medicaid | VT |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | 0890000286 (Vermont) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Glenn Mitchell Cratty, LICSW Po Box 29, 341 Vt Rt 315, Rupert, VT 05768-0029 Ph: (802) 394-7814 | Mr Glenn Mitchell Cratty, LICSW 341 Vt Rt 315, Rupert, VT 05768-0029 Ph: (802) 287-1515 |
News Archive
The Associated Press: The new health law "starts delivering protections and dollars-and-cents benefits that Americans can grasp. But it won't affect all consumers the same way, which may cause confusion." The AP walks consumers through some of the provisions in a question and answer format (Johnson, 9/22).
Donor kidneys can be successfully transplanted even if there is strong tissue incompatibility between donor and recipient. An interdisciplinary working group headed by Dr. Christian Morath, senior consultant at the Department of Nephrology at Heidelberg University Hospital (Medical Director: Professor Dr. Martin Zeier) and Professor Dr. Caner S-sal, head of antibody laboratory in the Department of Transplantation Immunology, showed in a study of 34 sensitized high-risk patients that the success rate in these patients was not different from the success rate of patients with a low immunological risk.
Adaptimmune, the T cell therapy company pioneering enhanced T cell receptor-driven T cells for the treatment of cancer and infectious disease, announces two new Board appointments with immediate effect. Dr Jonathan Knowles joins the Board as a non-executive director and Dr Helen Tayton-Martin, Adaptimmune's Chief Operating Officer, becomes an executive director.
EKF, announces today that the Quo-Test, its glycated haemoglobin analyser for near-patient monitoring of diabetes will be on show at Heart UK.
Researchers at the National Institute of Physiological Science have revealed that mutual eye contact synchronizes spontaneous activity in specific areas of the brains of two interacting parties. The finding indicates that this synchronized brain activity is crucial in establishing and facilitating face-to-face social interaction.
› Verified 2 days ago